Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GS.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GS.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GS.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.93ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.93EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.93EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.93ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.93ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GS.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.2.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.2.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.4.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.4.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.4.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GE.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GE.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.93EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.93EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GE.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GE.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GE.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GE.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.18ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.93ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.2.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.4.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used